首页> 美国卫生研究院文献>Food Science and Biotechnology >Monitoring of the amphetamine-like substances in dietary supplements by LC-PDA and LC–MS/MS
【2h】

Monitoring of the amphetamine-like substances in dietary supplements by LC-PDA and LC–MS/MS

机译:通过LC-PDA和LC-MS / MS监测膳食补充剂中的苯丙胺样物质

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Recently, amphetamine-like substances derived from the β-phenylethylamine core structure have been detected in dietary supplements. Especially, β-methylphenylethylamine (BMPEA), an amphetamine isomer, has been found in dietary supplements labeled as containing Acacia rigidula. The U. S. Food and Drug Administration determined that BMPEA is not naturally present in food and does not meet the statutory definition of a dietary ingredient. In addition, BMPEA has been classified as a psychotropic drug in South Korea and a doping substance by the World Anti-Doping Agency. The aim of this study was to determine whether dietary supplements contained amphetamine and amphetamine-like substance, including β-phenylethylamine (β-PEA) and BMPEA using LC-PDA and LC–MS/MS. In 10 of 110 samples, illegally added compounds were detected in the following ranges; β-PEA 1.4–122.0 mg/g and BMPEA 4.7–37.6 mg/g. This study will contribute to enhancement of food safety in the South Korea.
机译:最近,在膳食补充剂中检测到了源自β-苯乙胺核心结构的苯丙胺样物质。特别是,在标记为含有硬木相思的膳食补充剂中发现了苯丙胺异构体β-甲基苯乙胺(BMPEA)。美国食品药品监督管理局确定BMPEA不是天然存在于食品中,也不符合饮食成分的法定定义。此外,BMPEA在韩国被归类为精神药物,并被世界反兴奋剂机构归类为掺杂物质。这项研究的目的是使用LC-PDA和LC-MS / MS确定膳食补充剂中是否含有苯丙胺和苯丙胺样物质,包括β-苯乙胺(β-PEA)和BMPEA。在110个样本中,有10个在以下范围内检测到非法添加的化合物; β-PEA1.4–122.0 mg / g和BMPEA 4.7–37.6 mg / g。这项研究将有助于提高韩国的食品安全性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号